Acupuncture in the Prevention of Chemotherapy-induced Nausea and Vomiting: A Meta-analysis of Randomized Controlled Studies

Nausea and vomiting caused by chemotherapy represent one of the most common and distressing side effects faced by cancer patients. About eight out of every ten people undergoing chemotherapy experience these symptoms, and some medications such as cisplatin cause nausea and vomiting in nearly 100% of cases. Beyond immediate discomfort, these reactions can cause serious complications such as malnutrition, electrolyte imbalance in the blood, and may even lead the patient to abandon cancer treatment. Western medicine has medications to control these symptoms, but they are not always fully effective and may cause other side effects.

It is in this setting that acupuncture emerges as a promising alternative, having been recognized since 1997 by the U.S. National Institutes of Health as effective for the treatment of chemotherapy-induced nausea and vomiting.

This study aimed to rigorously evaluate the efficacy of acupuncture in preventing these symptoms through a meta-analysis, which is a type of research that combines results from several smaller studies to obtain more reliable conclusions. The researchers searched for scientific studies in six different databases, looking for randomized clinical trials (considered the gold standard in medical research) that compared patients treated with acupuncture in addition to conventional treatment versus patients who received only standard treatment. After careful selection, 18 studies involving a total of 1,135 patients with different types of cancer were included. The methodological quality of each study was carefully evaluated using specific tools to detect possible biases or flaws in the research design.

The results were extremely encouraging for patients and professionals interested in integrative treatments. The analysis showed that acupuncture, when combined with standard treatment, was significantly more effective than conventional treatment alone in preventing nausea and vomiting. Specifically, 85% of patients who received acupuncture had symptom improvement, compared with 76% in the control group. For nausea alone, 80% of patients treated with acupuncture were free of this symptom, compared with only 60% of the control group.

As for vomiting, 87% of patients in the acupuncture group did not present this problem, compared with 66% of the group that received only conventional medication. Surprisingly, the benefits extended beyond the main symptoms, with significant reductions in other chemotherapy side effects such as loss of appetite, constipation, and diarrhea. The most frequently used acupuncture points were Zusanli (located on the leg), Neiguan (on the wrist), and Zhongwan (on the abdomen), all traditionally associated with the treatment of digestive problems in Chinese medicine.

For patients considering acupuncture as a complement to oncologic treatment, these results offer real hope for relief from the suffering caused by chemotherapy side effects. Acupuncture has been shown to be a safe intervention that can significantly improve quality of life during cancer treatment, allowing patients to complete their chemotherapy cycles with less discomfort. For healthcare professionals, the study offers solid scientific evidence to recommend acupuncture as part of an integrated oncologic care plan. It is important to note that acupuncture does not replace conventional antiemetic medications but rather enhances their effects when used in combination.

The ease of application, low cost, and absence of significant side effects make acupuncture a particularly attractive option for healthcare systems seeking cost-effective approaches.

However, the study presents some important limitations that should be considered. The main methodological difficulty is that, unlike medication studies, it is practically impossible to fully "blind" acupuncture studies — both patients and acupuncturists know that treatment is being performed. This may introduce bias into the results. In addition, the experience and technique of different acupuncturists varied between studies, which may have influenced the results.

Some included studies had small patient samples, which reduces statistical reliability. Assessment of nausea and vomiting also depended largely on subjective patient reports rather than objective measurements, and many studies did not adequately report possible adverse effects of acupuncture or did not provide long-term follow-up of patients.

Despite these limitations, the evidence is sufficiently robust to encourage the integration of acupuncture into supportive cancer care. The authors recommend that future studies include larger patient samples, better standardize acupuncture protocols, and use more objective measures to assess outcomes. For patients interested in this approach, it is advisable to seek out qualified acupuncturists who are experienced in treating chemotherapy side effects, always in coordination with the oncology team. This study represents an important milestone in the scientific validation of complementary practices in oncology, offering patients a valuable additional tool to face the challenges of cancer treatment with greater comfort and dignity.